Endothelin-1 release in acute myocardial infarction as a predictor of long-term prognosis and no-reflow assessed by contrast-enhanced magnetic resonance imaging

American Heart Journal

Volumn 159, Issue 5, 2010, Pages 882-890

  Eitel, Ingo ^a   Nowak, Marek ^a   Stehl, Clemens ^a   Adams, Volker ^a   Fuernau, Georg ^a   Hildebrand, Lysann ^a   Desch, Steffen ^a   Schuler, Gerhard ^a   Thiele, Holger ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN 1; FIBRINOGEN RECEPTOR ANTAGONIST; GADOBUTROL; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; CONGESTIVE HEART FAILURE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DEATH; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REPERFUSION; HEART REINFARCTION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NO REFLOW PHENOMENON; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN SECRETION; REPERFUSION INJURY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; ENDOTHELIN-1; FEMALE; HUMANS; IMAGE ENHANCEMENT; KAPLAN-MEIERS ESTIMATE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NO-REFLOW PHENOMENON; PROGNOSIS; PROSPECTIVE STUDIES; ROC CURVE;

EID: 77951547489     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.02.019     Document Type: Article

References (33)

1. van de Werf F., Bax J., Betriu A., et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 29 (2008) 2909-2945
2. Keeley E.C., Boura J.A., and Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361 (2003) 13-20
3. Kloner R.A., Ganote C.E., and Jennings R.B. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 54 (1974) 1496-1508
4. Niccoli G., Burzotta F., Galiuto L., et al. Myocardial no-reflow in humans. J Am Coll Cardiol 54 (2009) 281-292
5. Ito H. No-reflow phenomenon and prognosis in patients with acute myocardial infarction. Nat Clin Pract Cardiovasc Med 3 (2006) 499-506
6. Wu K.C., Zerhouni E.A., Judd R.M., et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 97 (1998) 765-772
7. Nijveldt R., Beek A.M., Hirsch A., et al. Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury. J Am Coll Cardiol 52 (2008) 181-189
8. Niccoli G., Lanza G.A., Shaw S., et al. Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization. Eur Heart J 27 (2006) 1793-1798
9. Stewart D.J., Kubac G., Costello K.B., et al. Increased plasma endothelin-1 in the early hours of acute myocardial infarction. J Am Coll Cardiol 18 (1991) 38-43
10. Imaizumi T., Nejima J., Kiuchi K., et al. Dynamics and source of endothelin-1 and interleukin-6 following coronary reperfusion in patients with acute myocardial infarction. J Nippon Med Sch 74 (2007) 131-147
11. Omland T., Lie R.T., Aakvaag A., et al. Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction. Circulation 89 (1994) 1573-1579
12. Yip H.K., Wu C.J., Chang H.W., et al. Prognostic value of circulating levels of endothelin-1 in patients after acute myocardial infarction undergoing primary coronary angioplasty. Chest 127 (2005) 1491-1497
13. Katayama T., Yano K., Nakashima H., et al. Clinical significance of acute-phase endothelin-1 in acute myocardial infarction patients treated with direct coronary angioplasty. Circ J 69 (2005) 654-658
14. Wagner A., Mahrholdt H., Holly T.A., et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 361 (2003) 374-379
15. Thiele H., Hildebrand L., Schirdewahn C., et al. High-dose N-acetylcystein versus placebo to prevent contrast-induced nephropathy and myocardial reperfusion injury in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. J Am Coll Cardiol (2009) [in press]
16. van 't Hof A.W., Liem A., Suryapranata H., et al. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation 97 (1998) 2302-2306
17. Schroder R. Prognostic impact of early ST-segment resolution in acute ST-elevation myocardial infarction. Circulation 110 (2004) e506-e510
18. Bondarenko O., Beek A.M., Hofman M.B., et al. Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR. J Cardiovasc Magn Reson 7 (2005) 481-485
19. Nijveldt R., Hofman M.B., Hirsch A., et al. Assessment of microvascular obstruction and prediction of short-term remodeling after acute myocardial infarction: cardiac MR imaging study. Radiology 250 (2009) 363-370
20. Bohm F., and Pernow J. The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovasc Res 76 (2007) 8-18
21. Tsutamoto T., Wada A., Hayashi M., et al. Relationship between transcardiac gradient of endothelin-1 and left ventricular remodelling in patients with first anterior myocardial infarction. Eur Heart J 24 (2003) 346-355
22. Wagner O.F., Christ G., Wojta J., et al. Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 267 (1992) 16066-16068
23. Amado L.C., Kraitchman D.L., Gerber B.L., et al. Reduction of "no-reflow" phenomenon by intra-aortic balloon counterpulsation in a randomized magnetic resonance imaging experimental study. J Am Coll Cardiol 43 (2004) 1291-1298
24. Tamareille S., Achour H., Amirian J., et al. Left ventricular unloading before reperfusion reduces endothelin-1 release and calcium overload in porcine myocardial infarction. J Thorac Cardiovasc Surg 136 (2008) 343-351
25. Galiuto L., DeMaria A.N., del Balzo U., et al. Ischemia-reperfusion injury at the microvascular level: treatment by endothelin A-selective antagonist and evaluation by myocardial contrast echocardiography. Circulation 102 (2000) 3111-3116
26. Yellon D.M., and Hausenloy D.J. Myocardial reperfusion injury. N Engl J Med 357 (2007) 1121-1135
27. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med 312 (1985) 932-936
28. Schroder R., Dissmann R., Bruggemann T., et al. Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction. J Am Coll Cardiol 24 (1994) 384-391
29. Santoro G.M., Valenti R., Buonamici P., et al. Relation between ST-segment changes and myocardial perfusion evaluated by myocardial contrast echocardiography in patients with acute myocardial infarction treated with direct angioplasty. Am J Cardiol 82 (1998) 932-937
30. Orn S., Manhenke C., Greve O.J., et al. Microvascular obstruction is a major determinant of infarct healing and subsequent left ventricular remodelling following primary percutaneous coronary intervention. Eur Heart J 30 (2009) 1978-1985
31. Watanabe T., Suzuki N., Shimamoto N., et al. Contribution of endogenous endothelin to the extension of myocardial infarct size in rats. Circ Res 69 (1991) 370-377
32. Fraccarollo D., Hu K., Galuppo P., et al. Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rats with myocardial infarction: possible involvement of myocardial endothelin system in ventricular remodeling. Circulation 96 (1997) 3963-3973
33. Clozel M., Qiu C., Qiu C.S., et al. Short-term endothelin receptor blockade with tezosentan has both immediate and long-term beneficial effects in rats with myocardial infarction. J Am Coll Cardiol 39 (2002) 142-147